Welcome Visitor, Sign Up for Free!

Hospira Issues Nationwide Recall of Sodium Chloride Injection

En Español

Hospira sodium chloride recallOn March 29, 2013, Hospira, Inc., announced a nationwide user-level recall of a lot of 0.9% Sodium Chloride Injection due to a customer report of brass particulates found in the container.

Sodium Chloride Injections are typically used as a source of electrolytes and for hydration. The lot affected is 0.9% Sodium Chloride Injection, USP, 1000 mL, Flexible Container, NDC 0409-7983-09.

The particulates, described as small grey/brown particles, have been identified as containing copper, zinc and lead. If undetected, solution containing brass particulate may result in blockage of small blood vessels and in the worst-case scenario, copper toxicity may result in more severe results such as hemolysis and liver toxicity which may lead to liver failure which can be fatal.

The cause of this is currently pending investigation. While no adverse effects have been reported associated with this issue, the recall is being conducted as a precaution.